Image source: Adobe
Exoskeletons and rehabilitation robotics have moved beyond their niche status. The market segment is experiencing double-digit annual growth, attracting the attention of companies, investors, and professionals alike. Exoskeletons are wearable, mechanical, or motorized devices that assist or augment the movements of the human body. The term “rehabilitation robotics” refers to robot-assisted therapy systems that support or partially automate motor rehabilitation, for example, following a stroke or in cases of spinal cord injuries.
Companies seeking to establish themselves in this field and professionals planning a targeted career move are asking themselves the same question: What does this growth mean in concrete terms?
The segment can be divided into three areas. Industrial exoskeletons, also known as wearable robotics (robotics worn on the body and used in logistics, construction, and manufacturing to alleviate the strain of physically demanding work), focus on prevention and ergonomics. Medical exoskeletons, on the other hand, address clinical and home-based rehabilitation. Rehabilitation robots include inpatient and outpatient systems for the rehabilitation of arms, hands, legs, and gait.
Market figures vary depending on the source and segment definition, but they show a clear trend. For example, Mordor Intelligence estimates the global exoskeleton market at approximately $0.73 billion in 2025, with a forecast of $2.35 billion by 2031 at a compound annual growth rate (CAGR) of about 20 to 21 percent. For rehabilitation robots, figures of $1.5 to 1.8 billion (2025/2026) are cited, with a projection of approximately $3.9 billion by 2031 at a CAGR of about 17 percent.
Three structural drivers are behind this trend: demographic change, with a growing number of older patients; the shortage of skilled workers in therapeutic professions and the resulting pressure to automate; and technological maturity, driven by lighter materials, improved sensor technology, and AI-powered control systems. This dynamic offers companies early opportunities for differentiation but requires multi-year planning horizons with significant capital and development expenditures. For entrants, the field is still young enough to allow them to position themselves without facing firmly established competition.
In practice, the technology is used in three key areas. In acute care and rehabilitation clinics, exoskeletons and robotic systems enable intensive gait training and arm-and-hand rehabilitation following a stroke or spinal cord injury. Thanks to more compact systems and soft robotics (soft, flexible robotic components), the technology is now being applied in outpatient occupational therapy and, increasingly, in home settings. In the industrial sector, exoskeletons are used as occupational safety measures in logistics, manufacturing, and maintenance.
The regulatory context is complex. Medical exoskeletons generally fall into risk classes IIa or IIb under the MDR (Medical Device Regulation, EU regulation for medical devices, effective since 2021) and require a CE mark, which certifies compliance with European safety and performance requirements. In the U.S., the FDA (Food and Drug Administration) determines market access through the 510(k) process or de novo classification. Although reimbursement by payers is trending positively, it remains inconsistent internationally. Clinical evidence is the decisive factor here, as intensive, repetitive training has been shown to promote neuroplasticity, that is, the brain’s ability to form new neural connections following injuries.
For companies, this effort also provides competitive protection through high barriers to market entry. In our consulting practice, we regularly observe that the department responsible for approval procedures and regulatory compliance for medical devices (Regulatory Affairs) is among the most difficult roles to fill in this sector. For candidates, this means that those with expertise in CE, FDA, and HTA (Health Technology Assessment, the systematic evaluation of medical technologies in terms of benefits and costs) are in short supply.
The demand is concentrated in four core roles. Biomedical engineers are responsible for the development and integration of actuators (mechanical drives that generate or assist movement) as well as sensors and control algorithms. Regulatory affairs specialists and clinical affairs professionals oversee the approval process and post-market surveillance (systematic market monitoring after product approval to ensure safety). Market reports explicitly identify physical and occupational therapists with experience in rehabilitation robotics as a bottleneck. Product managers with the ability to bridge the gap between technology and the clinical user environment fill the gap between development and the market.
So-called “T-shaped” profiles are in particularly high demand. This concept describes deep specialization in one area, such as robotics engineering or neurorehabilitation, combined with a solid foundational understanding of related fields such as regulatory affairs, clinical workflows, and cost-effectiveness. This profile is structurally valuable in the field, as development work is inherently interdisciplinary.
In our industries, we’ve observed that traditional engineering and therapy training programs rarely fully cover the necessary interdisciplinary skills. Targeted continuing education through certificate programs, interdisciplinary projects, and clinical collaborations is therefore not an optional extra but a structural necessity. For companies, this means: Those who simply wait for a fully trained specialist will be waiting a long time. Investments in continuing education and attractive career paths are a strategic necessity.
The growth narrative needs a factual counterpoint. Three practical hurdles deserve special attention in this regard.
Clinical acceptance is not a given. Rehabilitation teams must be convinced of the added value, safety, and practicality of the systems. In addition to the technology itself, change management (structured support for change processes within organizations) and training are also crucial.
The reimbursement landscape remains inconsistent. Despite positive developments, coverage by health insurance plans and insurers remains a key business risk that hinders market access and scaling.
From a technical standpoint, personalization has not yet been fully achieved. AI-driven adaptation to individual anatomical and neurophysiological parameters (measurable biological characteristics of the nervous system) remains an ongoing development challenge.
Added to this is a trend toward consolidation. M&A (Mergers & Acquisitions) is a recurring pattern in high-growth medtech segments. Smaller specialists are acquired by well-capitalized companies, which presents both exit opportunities and restructuring risks. For job applicants, the following applies: Those who can demonstrate a proven track record of contributing to product and evidence development are in a more stable position, even during periods of upheaval.
Exoskeletons and rehabilitation robotics are no longer just promises for the future. The segment is growing measurably, the demand is real, and the structural drivers will not slow down. For companies, the rule is: Those who invest now in regulatory expertise, clinical evidence, and specialized talent will build a lead that cannot be caught up with in the short term.
This field offers candidates above-average opportunities for professional development, but requires a willingness to actively develop cross-functional skills. The crucial question is not whether positioning oneself in this market makes sense, but when and how to do so strategically.
If you are looking for qualified and motivated specialists and executives for your company, we can support you with our specialized network. Especially in a field like rehabilitation robotics and medical technology, where regulatory expertise and clinical understanding must go hand in hand, the right candidates are rare and hard to find. For over 15 years, the recruitment consultants at BESTMINDS have been filling vacancies in the medical technology, healthcare, life sciences / pharma, energy / utility, and IT / media sectors with a wealth of expertise and dedication. We’ll find the right candidates for you in a fair, loyal, and discreet manner. Contact us for a no-obligation initial consultation so we can fill your vacancies quickly and effectively.
